Search results
Results from the WOW.Com Content Network
(The current holy grail in psychiatric research is to develop a blood test or some other method of identifying people likely to get schizophrenia. But some experts and advocates worry about over-diagnosis, over-medication, and other negative consequences of finding and possibly treating the disease before symptoms even appear.)
Schizophrenia is diagnosed 1.4 times more frequently in males than females, and typically appears earlier in men [7] —the peak ages of onset schizophrenia are 20–28 years for males and 26–32 years for females. [10] Early Onset schizophrenia in childhood, before the age of 13 can sometimes occur.
Lynn Eleanor DeLisi (née Moskowitz) is an American psychiatrist known for her research on schizophrenia. She is an attending psychiatrist at the VA Boston Healthcare System and a professor of psychiatry at Harvard Medical School. She is the editor-in-chief of Psychiatry Research and the president of the Schizophrenia International Research ...
The NIH, in turn, is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research. NIMH is the largest research organization in the world specializing in mental illness. Shelli Avenevoli is the current acting director of ...
Obsessive-compulsive disorder is two to three times as common in Latin America, Africa, and Europe as in Asia and Oceania. [7] Schizophrenia appears to be most common in Japan, Oceania, and Southeastern Europe and least common in Africa. [8] Bipolar disorder and panic disorder have very similar rates around the world. [9] [10]
It is an official journal of the Schizophrenia International Research Society and was established in 1988. The editor-in-chief is Matcheri Keshavan and the former editors are Henry Nasrallah (University of Cincinnati) and Lynn DeLisi (Harvard Medical School). According to Schizophrenia Research 's original mission statement, the journal is aimed at
Edwin Fuller Torrey (born September 6, 1937), is an American psychiatrist and schizophrenia researcher. He is associate director of research at the Stanley Medical Research Institute [1] (SMRI) and founder of the Treatment Advocacy Center (TAC), a nonprofit organization whose principal activity is promoting the passage and implementation of outpatient commitment laws and civil commitment laws ...
The Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard is a multi-disciplinary biomedical research program located in Cambridge, Massachusetts that studies the biological basis of psychiatric disease. The center was founded in 2007 with funding from philanthropists Ted and Vada Stanley. [1]